Legrand C - Search Results

1

Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial.

Legrand C, Duchateau L, Sylvester R, Janssen P, van der Hage JA, van de Velde CJ, Therasse P. Legrand C, et al. Clin Trials. 2006;3(1):10-8. doi: 10.1191/1740774506cn132oa. Clin Trials. 2006. PMID: 16539086

2

A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model.

Legrand C, Ducrocq V, Janssen P, Sylvester R, Duchateau L. Legrand C, et al. Stat Med. 2005 Dec 30;24(24):3789-804. doi: 10.1002/sim.2475. Stat Med. 2005. PMID: 16320274

3

Treatment outcome studies. pitfalls in current methods and practice.

Legrand C, Sylvester R, Duchateau L, Janssen P, Therasse P. Legrand C, et al. Eur J Cancer. 2002 Jun;38(9):1173-80. doi: 10.1016/s0959-8049(02)00085-0. Eur J Cancer. 2002. PMID: 12044502 Review.

4

Validation of prognostic indices using the frailty model.

Legrand C, Duchateau L, Janssen P, Ducrocq V, Sylvester R. Legrand C, et al. Lifetime Data Anal. 2009 Mar;15(1):59-78. doi: 10.1007/s10985-008-9092-2. Epub 2008 Jul 11. Lifetime Data Anal. 2009. PMID: 18618249

5

Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer Group.

Francart J, Legrand C, Sylvester R, Van Glabbeke M, van Meerbeeck JP, Robert A. Francart J, et al. Among authors: legrand c. J Clin Oncol. 2006 Jul 1;24(19):3007-12. doi: 10.1200/JCO.2005.05.1359. J Clin Oncol. 2006. PMID: 16809726

6

Statistical methodology of phase III cancer clinical trials: advances and future perspectives.

Sylvester R, Van Glabbeke M, Collette L, Suciu S, Baron B, Legrand C, Gorlia T, Collins G, Coens C, Declerck L, Therasse P. Sylvester R, et al. Among authors: legrand c. Eur J Cancer. 2002 Mar;38 Suppl 4:S162-8. doi: 10.1016/s0959-8049(01)00442-7. Eur J Cancer. 2002. PMID: 11858987

7

A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials.

Francart J, Vaes E, Henrard S, Legrand C, Baas P, Gaafar R, van Meerbeeck JP, Sylvester R, Robert A. Francart J, et al. Among authors: legrand c. Eur J Cancer. 2009 Sep;45(13):2304-11. doi: 10.1016/j.ejca.2009.04.028. Epub 2009 Jun 6. Eur J Cancer. 2009. PMID: 19502050

8

Frailty modelling for survival data from multi-centre clinical trials.

Ha ID, Sylvester R, Legrand C, Mackenzie G. Ha ID, et al. Among authors: legrand c. Stat Med. 2011 Jul 30;30(17):2144-59. doi: 10.1002/sim.4250. Epub 2011 May 12. Stat Med. 2011. PMID: 21563206 Free PMC article.

9

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H. van Dongen JA, et al. Among authors: legrand c. J Natl Cancer Inst. 2000 Jul 19;92(14):1143-50. doi: 10.1093/jnci/92.14.1143. J Natl Cancer Inst. 2000. PMID: 10904087 Clinical Trial.

10

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen.

Fentiman IS, van Zijl J, Karydas I, Chaudary MA, Margreiter R, Legrand C, Therasse P; EORTC. Fentiman IS, et al. Among authors: legrand c. Eur J Cancer. 2003 Feb;39(3):300-8. doi: 10.1016/s0959-8049(02)00672-x. Eur J Cancer. 2003. PMID: 12565981 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

486 results

Search Page

Filters